Nuvalent
Stock Forecast, Prediction & Price Target
Nuvalent (NUVL) stock Price Target by analysts
$114.8
Potential upside: 53.06%
Nuvalent price prediction
What is Nuvalent stock analysts` prediction?
Nuvalent stock forecast: Based on 5 Wall Street analysts` predicted price targets for Nuvalent in the last 3 months, the avarage price target is $114.8, with a high forecast of $NaN. The average price target represents a 53.06% change from the last price of $75.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Nuvalent stock Price Target by analysts
Full breakdown of analysts given Nuvalent price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Etzer Darout BMO Capital | 0% 0/1 | 10 months ago | $134 78.66% upside | $69.99 | StreetInsider | Previous targets (0) |
David Dai UBS | 0% 0/1 | 11 months ago | $100 33.33% upside | $93.71 | StreetInsider | Previous targets (0) |
Christopher Raymond Raymond James | 0% 0/1 | 12 months ago | $100 33.33% upside | $87.45 | StreetInsider | Previous targets (0) |
Kelsey Goodwin Guggenheim | 0% 0/1 | 12 months ago | $105 40% upside | $110.25 | TheFly | Previous targets (0) |
Bradley Canino Stifel Nicolaus | 0% 0/2 | 12 months ago | $135 80% upside | $87.45 | StreetInsider | Previous targets (1) |
Bradley Canino Stifel Nicolaus | 0% 0/2 | about 1 year ago | $115 53.33% upside | $73.63 | TheFly | Previous targets (1) |
Roger Song Jefferies | 0% 0/1 | over 1 year ago | $97 29.33% upside | $64.75 | StreetInsider | Previous targets (0) |
Christopher Liu Leerink Partners | 0% 0/1 | over 1 year ago | $110 46.66% upside | $75.09 | TheFly | Previous targets (0) |
Nuvalent Financial Estimates
Nuvalent Revenue Estimates
Nuvalent EBITDA Estimates
Nuvalent Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $7.98M Low: $7.98M High: $7.98M avg. 0% | Avg: $28.57M Low: $28.57M High: $28.57M avg. 258.13% | Avg: $181.87M Low: $181.87M High: $181.87M avg. 536.39% | Avg: $338.03M Low: $338.03M High: $338.03M avg. 85.86% |
Net Income
% change YoY
| $-46.33M N/A | $-73.34M -58.28% | $-126.21M -72.08% | Avg: $-237.45M Low: $-254.43M High: $-154.87M avg. -88.12% | Avg: $-264.94M Low: $-302.17M High: $-129.25M avg. -11.57% | Avg: $-161.66M Low: $-161.66M High: $-161.66M avg. 38.98% | Avg: $-67.15M Low: $-67.15M High: $-67.15M avg. 58.46% |
EBITDA
% change YoY
| $-45.81M N/A | $-86.10M -87.93% | $-149.49M -73.60% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.96 N/A | -$1.48 -54.16% | -$2.17 -46.62% | Avg: -$3.66 Low: -$4.37 High: -$2.66 avg. -68.55% | Avg: -$3.99 Low: -$5.19 High: -$2.22 avg. -9.15% | Avg: -$2.78 Low: -$2.78 High: -$2.78 avg. 30.45% | Avg: -$1.15 Low: -$1.15 High: -$1.15 avg. 58.46% |
Operating Expenses
% change YoY
| $45.81M N/A | $86.10M 87.93% | $149.49M 73.60% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Nuvalent stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -0.56% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -254.43M, average is -237.45M and high is -154.87M.
What is Nuvalent stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 220.09% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $7.98M, average is $7.98M and high is $7.98M.
What is Nuvalent stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 2.80% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$4.37, average is -$3.66 and high is $-2.66.
What is the best performing analyst?
In the last twelve months 5 analysts have been covering Nuvalent stock. The most successful analyst is Etzer Darout.